Kisspeptin administration in women with hypoactive sexual desire disorder
Kisspeptin modulated sexual/emotional brain processing; 32 participants completed evaluable crossover testing.
What this study tells us
Participants were assigned to comparison groups by chance, usually with placebo and/or blinding to reduce bias. This is a strong design for testing cause and effect, but the population, duration and endpoints still limit what can be concluded.
Women with HSDD
n=40
Kisspeptin modulated sexual/emotional brain processing; 32 participants completed evaluable crossover testing.
Short mechanistic study; not a long-term clinical-outcome trial.
Need help with terms such as randomized, placebo, endpoint or sample size? Open the glossary →
Key result
Kisspeptin modulated sexual/emotional brain processing; 32 participants completed evaluable crossover testing.